Neuronoff, Inc.

Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body. The primary focus is on treatments for chronic pain.

https://www.neuronoff.com/

11-50 employees

Growth Trajectory

Neuronoff's growth potential lies in expanding the applications of Injectrode beyond chronic pain, with active research into bladder dysfunction, hypertension, and other conditions. They are also focused on simplifying the placement and removal procedures to make neuromodulation more accessible to both clinicians and patients. Achieving regulatory approvals and securing reimbursement coverage will be crucial for their market expansion.

Technical Challenges

Ensuring long-term device stability

Optimizing external power delivery

Preventing device migration

Simplifying placement and removal procedures

Adapting the Injectrode for various nerve targets and patient anatomies

Addressing the transcutaneous stimulation for eCAP measurements

Documenting the MRI conditionality of the Injectrode

Tech Stack

NeuromodulationElectrical StimulationHelical Wire StructureExternal Pulse Generator (EPG)UltrasoundFluoroscopyMRISpinal Cord Stimulation (SCS)Dorsal Root Ganglion (DRG) StimulationPeripheral Nerve Stimulation (PNS)SquarespaceGoogle Tag ManagerjsDelivr CDNeCAP

Team Size

CEO

CSO

Directors (Regulatory Strategy, Clinical Affairs, R&D)

Clinical Advisory Board

Key Risks

Adoption of the new Injectrode neuromodulation technique by clinicians may be slow.

Ensuring long-term device stability and efficacy remains a technical challenge.

Competition from established pain management methods like opioids and nerve ablation could limit market share.

Stringent prior authorization requirements by insurance providers may hinder patient access.

Delays in obtaining regulatory approvals could impact commercialization timelines.

Opportunities

Capitalizing on the growing demand for less invasive pain management solutions.

Expanding Injectrode applications to address a broader range of chronic conditions.

Partnering with pain management clinics and hospitals to facilitate adoption.

Improving external power delivery and device visualization to enhance efficacy.

Securing reimbursement coverage from insurance providers by demonstrating cost-effectiveness.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes